BioCentury
ARTICLE | Company News

Pharmos, Senju deal

September 5, 2000 7:00 AM UTC

PARS granted Senju rights in Japan, Korea and Australia to its loteprednol etabonate formulation patent in exchange for a $400,000 upfront payment and single-digit royalties. Loteprednol, an ophthalmi...